This inventor holds 1 USPTO granted patent. Top assignee: Aventis Pharma S.a.. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Gerald Perret - Innovator in Affinity Chromatography
Introduction
Gerald Perret is a notable inventor based in Paris, France. He has made significant contributions to the field of biochemistry, particularly in the area of affinity chromatography. His work has implications for medical research and therapeutic applications.
Latest Patents
Gerald Perret holds a patent for a "Method for affinity chromatography of antithrombin III." This invention is directed to an affinity chromatography column comprising the antithrombin III (ATIII) protein bound to a solid support. The method is characterized by its innovative approach to isolating this important protein, which plays a crucial role in blood coagulation.
Career Highlights
Gerald Perret is associated with Aventis Pharma S.A., a leading pharmaceutical company. His work at Aventis has allowed him to focus on developing advanced methodologies in biochemistry and pharmaceuticals. His expertise in affinity chromatography has positioned him as a valuable asset in the field.
Collaborations
Gerald has collaborated with Pierre Mourier, enhancing the research and development efforts in their projects. Their partnership has contributed to advancements in the understanding and application of antithrombin III in therapeutic contexts.
Conclusion
Gerald Perret's innovative work in affinity chromatography exemplifies the impact of scientific research on medicine. His contributions continue to influence the field and pave the way for future advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile